ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

House Republicans Move To Slash NIH Spending As Obama Calls For Renewed Investment in Science

February 18, 2011

Panel Unenthused About New Toxicity Testing Program

December 15, 1978

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986